Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
13,023,723
-
Share change
-
+163,474
-
Total reported value
-
$100,801,046
-
Put/Call ratio
-
43%
-
Price per share
-
$7.74
-
Number of holders
-
60
-
Value change
-
+$1,434,486
-
Number of buys
-
21
-
Number of sells
-
26
Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q3 2016
As of 30 Sep 2016 SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) had 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,023,723 shares of stock of the company.
Largest 10 holders included Wildcat Capital Management, LLC, Cormorant Asset Management, LLC, venBio Select Advisor LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., STATE STREET CORP, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, and FRANKLIN RESOURCES INC.
This table shows 60 institutional shareholders of the security as of 30 Sep 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.